INSM
INSMED INC
Latest close $99.79 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 5 parsed filing(s) · 2 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| JPMorgan Chase / Asset Management CIK0000019617 | Jun 30, 2026 observed Jul 22, 2026 filed · 22d Schedule 13G amendment | Earliest Schedule 13G amendment found | 10.4M | 12.00% | $106.62 | $106.64 | $99.79 |
| Fidelity / FMR CIK0000315066 | Mar 31, 2026 observed May 6, 2026 filed · 36d Initial Schedule 13G | Initial Schedule 13G | 13.1K | 12.00% | $163.52 | $137.09 | $99.79 |
| BlackRock CIK0002012383 | Dec 31, 2025 observed Jan 21, 2026 filed · 21d Schedule 13G amendment | Earliest Schedule 13G amendment found | 14.1M | 12.00% | $156.32 | $99.79 |